The Mark H Zangmeister Center — Columbus, Ohio

The Mark H Zangmeister Center is a clinical research site located in Columbus, Ohio, United States 43219.

Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.

The Mark H Zangmeister Center has participated in 236 clinical trials with 140 currently active.

Therapeutic areas: Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Sponsors: GOG Foundation, National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group.

Sponsor Feasibility Report

Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Mark H Zangmeister Center?

The Mark H Zangmeister Center has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Mark H Zangmeister Center conducted?

The Mark H Zangmeister Center has 236 clinical trials on record, with 140 currently active. Their work covers Ovarian Granulosa Cell Tumor, Ovarian Gynandroblastoma, Ovarian Sertoli-Leydig Cell Tumor.

Is The Mark H Zangmeister Center accredited by Crixeo Health?

The Mark H Zangmeister Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Mark H Zangmeister Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.